A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma

Collapse authors list.
Pratt, Guy, Yap, Christina, Oldreive, Ceri, Slade, Daniel, Bishop, Rebecca, Griffiths, Mike, Dyer, Martin JS, Fegan, Chris, Oscier, David, Pettitt, Andrew et al (show 9 more authors) , Matutes, Estella, Devereux, Stephen, Allsup, David, Bloor, Adrian, Hillmen, Peter, Follows, George, Rule, Simon, Moss, Paul and Stankovic, Tatjana (2018) A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY, 182 (3). pp. 429-433.

	Text PICLLe BJH letter-April 2017.docx - Author Accepted Manuscript Download (62kB)
	Text Letter_Table_1_25_01_2017.pdf - Author Accepted Manuscript Download (12kB)
	Text Letter_Table_2_25_01_2017.pdf - Author Accepted Manuscript Download (24kB)

Item Type:	Article
Uncontrolled Keywords:	chronic lymphocytic leukaemia, mantle cell lymphoma, DNA damage, olaparib
Depositing User:	Symplectic Admin
Date Deposited:	17 Sep 2018 10:45
Last Modified:	19 Jan 2023 01:18
DOI:	10.1111/bjh.14793
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3026120